Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Zymeworks Announces Abstract for Zanidatamab in First-line HER2-Expressing … – Business Wire,

Title: Phase (Ph) 2 Study of Zanidatamab + Chemotherapy (chemo) in … as several Phase 2 clinical trials for HER2-expressing gastroesophageal, …, Title: Phase (Ph) 2 Study of Zanidatamab + Chemotherapy (chemo) in … as several Phase 2 clinical trials for HER2-expressing gastroesophageal, …, Read More

Scroll to Top